Skip to main content

Joseph Eron named to endowed chair

March 17, 2021
UNC School of Medicine Dean Wesley Burks named Infectious Diseases Chief Joseph Eron, Jr., MD, the Herman and Louise Smith Distinguished Professor of Medicine on March 10, 2021. The honor acknowledges his decades-long commitment to infectious diseases along with his work this past year during the COVID-19 pandemic. We are...

Michael Hudgens Appointed Associate Chair of Biostatistics

February 17, 2021
Michael Hudgens, UNC CFAR Biostatistics Core Director, is the new Associate Chair of the Biostatistics Department! Dr. Hudgens joins Lisa LaVange, Department Chair, and brings many years of experience to UNC’s top-ranked biostatistics department. Hudgens has co-authored more than 200 peer-reviewed papers in statistical journals such as Biometrics, Biometrika, JASA and...

Nature Highlights UNC HIV Research in ‘Best of’ List from 2020

January 22, 2021
UNC HIV researchers were featured in a recent Nature article titled, “Viruses, microscopy and fast radio bursts: 10 remarkable discoveries from 2020.” A study on HIV latency reversal from J. Victor Garcia, PhD, David Margolis, MD, and team (with Qura Therapeutics and Emory University) is listed as one of the...

UNC listed at #11 in top global universities for Infectious Diseases

January 4, 2021
US News and World Report lists UNC-Chapel Hill as the #11 top university for infectious diseases in the world! See the full list here for the top global universities for infectious diseases, based on their research performance in the field.   

Gates Foundation awards UNC Global Women’s Health $6.2 million to study pregnancy outcomes in Zambia

December 11, 2020
“UNC Global Women’s Health has received two new grants from the Bill and Melinda Gates Foundation for work on pregnancy outcomes in Zambia. The first grant funds the “Multi-omics for Mother and Infants (MOMI) Consortium,” which seeks to identify new predictive biomarkers for preterm birth, preeclampsia, stillbirth and fetal growth...

Three UNC faculty elected IDSA Fellows

December 7, 2020
The Infectious Diseases Society of America has elected Joseph Eron, MD; Anne Lachiewicz, MD, MPH; and Christopher Hurt, MD, to its latest group of Fellows of IDSA. This Fellowship in IDSA is the highest honor in the field of infectious diseases and is given to those who have achieved professional...

Tonia Poteat, PhD, featured as December 2020 SGM Health Researcher Spotlight

December 4, 2020
Dr. Tonia Poteat, PhD, MPH, PA-C, DFAAPA, is featured this month as the December 2020 SGM (Sexual & Gender Minority) Health Researcher Spotlight. See below for highlights and read the full interview here on the SGMRO website.  “Q: What organizational challenges have you faced? A: As one of the earlier...

NIH Re-Funds ACTG for the Next Seven Years

November 30, 2020
The AIDS Clinical Trials Group (ACTG) Network has been re-funded for the next seven years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The ACTG is the largest global HIV research network. Dr. Joe Eron, UNC CFAR Clinical Core Director,...

UNAIDS releases World AIDS Day report 2020 – Prevailing against pandemics by putting people at the centre

November 27, 2020
“Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too...

ACTG honors David Wohl, MD, with first Charles van der Horst Humanitarian Award

November 24, 2020
ACTG names second new award for former UNC neurology professor, Kevin Robertson. “The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician...

CFAR Directors recognized in 2020 Global Highly Cited Researchers List

November 19, 2020
“Twenty-one UNC School of Medicine and 16 other UNC-Chapel Hill researchers have been named in Clarivate’s 2020 list of Highly Cited Researchers™, scientific pioneers from around the world whose names are drawn from the publications that rank in the top 1% by citations for field and publication year in the...

‘Major advance’: Long-acting injectable more effective than daily pill in preventing HIV

November 17, 2020
“A long-acting injectable drug, cabotegravir, is safe and more effective than a daily pill in preventing HIV acquisition, according to results from a study of 3,127 cisgender women in sub-Saharan Africa. Led by UNC researchers beginning in November 2017, the study showed such promising results that a review board recommended...